Zobrazeno 1 - 10
of 11
pro vyhledávání: '"William Burman"'
Autor:
William Burman, Oxana Rucsineanu, C Robert Horsburgh, James Johnston, Susan E Dorman, Dick Menzies
Publikováno v:
PLoS Medicine, Vol 21, Iss 7, p e1004438 (2024)
In the Perspective, William Burman and colleagues advocate improving the safety and acceptability of treatment, rather than treatment-shortening, of rifampin-susceptible tuberculosis.
Externí odkaz:
https://doaj.org/article/0d39c7fb9cf34d35b0c6c50ac057da81
Autor:
Dick Menzies, Andrea Benedetti, Anita Paydar, Sarah Royce, Pai Madhukar, William Burman, Andrew Vernon, Christian Lienhardt
Publikováno v:
PLoS Medicine, Vol 6, Iss 9, p e1000150 (2009)
Externí odkaz:
https://doaj.org/article/ac32f36ae9dd47d8a67ecf9638f2f3bd
Autor:
Dick Menzies, Andrea Benedetti, Anita Paydar, Ian Martin, Sarah Royce, Madhukar Pai, Andrew Vernon, Christian Lienhardt, William Burman
Publikováno v:
PLoS Medicine, Vol 6, Iss 9, p e1000146 (2009)
BACKGROUND: Treatment regimens for active tuberculosis (TB) that are intermittent, or use rifampin during only the initial phase, offer practical advantages, but their efficacy has been questioned. We conducted a systematic review of treatment regime
Externí odkaz:
https://doaj.org/article/44a0e767b2284d05bd789d43dc246c48
Publikováno v:
PLoS Medicine, Vol 4, Iss 11, p e292 (2007)
Externí odkaz:
https://doaj.org/article/0bfa7b256bad41dba11a799f63dfa8d8
Autor:
A T, Podany, J, Leon-Cruz, J, Hakim, K, Supparatpinyo, A, Omoz-Oarhe, D, Langat, N, Mwelase, C, Kanyama, A, Gupta, C A, Benson, R E, Chaisson, S, Swindells, C V, Fletcher, William, Burman
Publikováno v:
J Antimicrob Chemother
Background The use of rifamycin antibiotics for TB prevention carries a risk of detrimental drug–drug interactions with concomitantly used ART. Objectives To evaluate the interaction of the antiretroviral drug nevirapine in combination with 4 weeks
Autor:
Payam, Nahid, Jussi, Saukkonen, William R, Mac Kenzie, John L, Johnson, Patrick P J, Phillips, Janet, Andersen, Erin, Bliven-Sizemore, John T, Belisle, W Henry, Boom, Annie, Luetkemeyer, Thomas B, Campbell, Kathleen D, Eisenach, Richard, Hafner, Jeffrey L, Lennox, Mamodikoe, Makhene, Susan, Swindells, M Elsa, Villarino, Marc, Weiner, Constance, Benson, William, Burman
Publikováno v:
American journal of respiratory and critical care medicine. 184(8)
The Centers for Disease Control and Prevention and National Institutes of Health convened a multidisciplinary meeting to discuss surrogate markers of treatment response in tuberculosis. The goals were to assess recent surrogate marker research and to
Publikováno v:
Medical Decision Making. 11:S45-S48
The authors compared the injury diagnoses and Injury Severity Scores (ISSs) generated by three data-collection and -coding methods, and examined the times needed and costs associated with the methods. One method involved direct electronic entry of in
Autor:
Michael, Saag, Rukmini, Balu, Elizabeth, Phillips, Philip, Brachman, Claudia, Martorell, William, Burman, Britt, Stancil, Michael, Mosteller, Cindy, Brothers, Paul, Wannamaker, Arlene, Hughes, Denise, Sutherland-Phillips, Simon, Mallal, Mark, Shaefer, C, Zurawski
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(7)
Background. Although the human leukocyte antigen (HLA)–B*5701 is highly associated with a hypersensitivity reaction (HSR) to abacavir (ABC), variable sensitivities have been reported when clinical data alone have been used to define an ABC HSR. Thi
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 12(2)
Publikováno v:
PLoS Medicine, Vol 4, Iss 11, p e292 (2007)
The time is now right for randomized trials of MDR-TB, say the authors, as the expansion of MDR-TB programs provides the setting in which trials can be implemented.